| Registration number: |
E024929 |
| European Patent number: |
EP3722415 |
| Application number: |
EP20161276.9 |
| Filing date of the application: |
05.01.2018 |
| Date of the grant of the European patent: |
06.11.2024 |
| Date of the publication of the translation: |
15.04.2025 |
| Status: |
European patent validated in Estonia |
| Fees paid for the years of validity: |
8 |
| IPC class: |
C12N 5/0783
C12M 1/04
|
| Examiner: |
Reet Kask
|
| Owner: |
Iovance Biotherapeutics, Inc. |
| Patent attorney: |
Margus Sarap |
| Estonian title |
Meetodid tuumorit infiltreerivate lümfotsüütide valmistamiseks ja nende kasutamine immunoteraapias |
| Translation of the patent specification:
|
Display translation of the patent specification
|
| |
|
| Display: |
EXAMINATION |
DATA OF THE FEES |
